La isquemia miocardica silente. Criterios actuales. Silent myocardial ischemia. Current criteria

Authors

  • Pedro Bazart Padrón Especialista de I Grado en Cardiología. Hospital Clínico Quirúrgico "León Cuervo Rubio". Pinar del Río.
  • Maribel Correa Torres Especialista de I Grado en Anestesia y Reanimación. Hospital Clínico Quirúrgico "León Cuervo Rubio". Pinar del Río.
  • Luis Benito Ramos Gutiérrez Especialista de I Grado en Medicina General Integral. Hospital Clínico Quirúrgico "León Cuervo Rubio". Pinar del Río.
  • Armando Martínez Fábregas Especialista de I Grado en Medicina Interna. Hospital Clínico Quirúrgico "León Cuervo Rubio". Pinar del Río.

Abstract

Esta revisión describe los criterios actuales para la definición, clasificación, diagnóstico y tratamiento de la isquemia miocárdica silente (IMS) así como su significado pronóstico en aquellos pacientes portadores de ella teniendo en cuenta las sugerencias del American College of Cardiology y la American Heart Association (ACC/AHA), se expone la importancia de la identificación, evaluación y prevención de los factores de riesgo más importantes que favorecen la aparición de la isquemia miocárdica, así como los más recientes adelantos en el manejo de esta entidad tanto desde el punto de vista farmacológico como no farmacológico (revascularización coronaria con angioplastía o cirugía). Conclusiones: La modificación, eliminación o control de los principales factores de riesgo cardiovascular susceptibles de manipulación y de las posibles causas desencadenantes de IMS una vez que esta ha sido identificada, continúan siendo los objetivos principales a alcanzar para disminuir la ¨carga isquémica total¨ y mejorar el pronóstico a largo plazo de estos pacientes. La elección del fármaco debe ser discriminada mediante criterios clínicos o derivados de exploraciones como prueba de esfuerzo, monitorización ambulatoria de holter o talio-201 de esfuerzo entre otros exámenes que se precisan de forma resumida en esta revisión.

DeCS: ISQUEMIA / clasificación/diagnóstico/tratamiento, CORAZON

ABSTRACT

The report describes the current criteria to the definition, classification, diagnosis and treatment of Silent Myocardial Ischemia (SMI) as well as the prognosis in patients suffering from SMI taking into account the suggestions of the American College or Cardiology (ACC) and the American Heart Association (AHA). The importance of the identification, assessment and prevention of the risk factors wish favors the onset of the MI are analysed and the current advantages on the management of this entity from the pharmacological and nonpharmacological view point (coronary revascularization with angioplasty and surgery). Conclusions: once SMI has been identified the mortification, elimination or control of the principal manageable cardiovascular risk factors and the possible causes of SMI onset continue being the principal aims to decrease the "total ischemic load" and improve the long - term prognosis of these patients. Drug's choice should be distinguished taking into account clinical criteria or by means of exercise test, ambulatory exercise monitoring by holter or talio 201 among other required examinations summarised on this report.

DeCS: ISCHEMIA/classification, /detection/management, MYOCARDIAL

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Bazart Padrón P, Correa Torres M, Ramos Gutiérrez LB, Martínez Fábregas A. La isquemia miocardica silente. Criterios actuales. Silent myocardial ischemia. Current criteria. Rev Ciencias Médicas [Internet]. 2012 Oct. 2 [cited 2025 Oct. 13];6(2):97-107. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/137

Issue

Vol. 6 No. 2 (2002)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/